Hap Trading, LLC Pacira Bio Sciences, Inc. Put Options Transaction History

Hap Trading, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 12, 2024	SELL	$11.7 - $28.46 $1.21 Million - $2.94 Million	-103,200 Reduced 82.23%	22,300 $113 Million
Q4 2023 Feb 14, 2024	SELL	$26.32 - $34.31 $631,680 - $823,440	-24,000 Reduced 16.05%	125,500 $784 Million
Q3 2023 Nov 09, 2023	BUY	$30.68 - $40.09 $4.59 Million - $5.99 Million	149,500 New	149,500 $4.59 Million
Q2 2020 Aug 10, 2020	SELL	$30.8 - $52.47 $1.97 Million - $3.35 Million	-63,800 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$28.4 - $50.7 $1.81 Million - $3.23 Million	63,800 New	63,800 $256,000

264

50.6M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $905M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.